Search results
Results from the WOW.Com Content Network
The selection and use of essential medicines: report of the WHO Expert Committee on Selection and Use of Essential Medicines, 2019 (including the 21st WHO Model List of Essential Medicines and the 7th WHO Model List of Essential Medicines for Children). Geneva: World Health Organization. 2019. hdl: 10665/330668. ISBN 978-92-4-121030-0.
Access to medicines refers to the reasonable ability for people to get needed medicines required to achieve health. [1] Such access is deemed to be part of the right to health as supported by international law since 1946. [2] The World Health Organization states that essential medicines should be available, of good quality, and accessible. [2]
Essential medicines are those that satisfy the priority health care needs of the population. [10] This remains the definition as of 2019. [1] The use of essential medicines lists has resulted in better quality of care and improved management of health resources in the most cost-effective manner.
ActionAid Kenya actively campaign for lower prices and greater availability of anti-retroviral (ARV) drugs for the poor. It is part of the Kenya Coalition on Access to Essential Medicine (KCAEM), which is made of various NGOs campaigning for greater access to medicine.
The WHO's Essential Medicines List, which includes treatments that the WHO regards as global standards that should be available everywhere, aims to help governments make the best choices for their ...
The selection and use of essential medicines: report of the WHO Expert Committee, 2017 (including the 20th WHO Model List of Essential Medicines and the 6th Model List of Essential Medicines for Children). Geneva: World Health Organization. hdl: 10665/259481. ISBN 978-92-4-121015-7. ISSN 0512-3054. WHO technical report series; no. 1006.
The mission of the Department of Essential Drugs and Medicines of the World Health Organization is "to help save lives and improve health by closing the huge gap between the potential that essential drugs have to offer and the reality that for millions of people – particularly the poor and disadvantaged – medicines are unavailable, unaffordable, unsafe or improperly used."
There is a strong emphasis on the need for national policy decisions and local ownership and implementation. In addition, a number of guiding principles for essential drug programs have emerged. The initial essential drugs list should be seen as a starting point. Generic names should be used where possible, with a cross-index to proprietary names.